Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Business News / Dr. Reddy's submits response to warning letter from USFDA
Business

Dr. Reddy's submits response to warning letter from USFDA

Dr. Reddy's submits response to warning letter from USFDA
Written by Kartikeya Jain
Dec 09, 2015, 01:25 pm 3 min read
Dr. Reddy's submits response to warning letter from USFDA
Credits:

Dr. Reddy's Laboratories submitted its response to the US health regulator on the notice it had received last month. It said that the "the company is in the process of shifting some of the products from these plants to other facilities and considering third party assessment for its plants". The US agency had wanted comprehensive evaluation of "inaccuracies in recorded and reported data".

Introduction
What is Dr. Reddy's?

Dr. Reddy's Laboratories is a multinational pharmaceutical company found in 1984 by Anji Reddy. It is based in Hyderabad, Telangana, India and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products. It has a net income of $350 million and employs 20,000-people.

Information
A trusted company

In 2014, Dr. Reddy Laboratories was listed among 1200 of India's most trusted brands according to the Brand Trust Report 2014, a study conducted by Trust Research Advisory- a brand analytics company.

6 Jul 2011
FDA slaps import ban on Reddy's Mexican plant

The USFDA had imposed an import ban on Dr. Reddy's Mexican facility until its manufacturing issues were resolved. The plant was cited for several manufacturing shortcomes, and the agency had warned the company in June 2011 that it would prohibit its products from the US market. The company was also a few weeks late in responding to the FDA's warning letter.

27 Jul 2012
FDA lifts ban from Reddy's mexican plant

The USFDA had lifted its ban on the import of nearly all drugs from a Mexican plant run by Dr. Reddy's Laboratories. The FDA said that concerns over potentially adulterated pharmaceuticals from Reddy's plant were resolved. The company said that FDA had indicated in an inspection report that it was satisfied with all the outstanding action points that Dr. Reddy's had submitted.

21 Aug 2015
CPSC accuses Dr. Reddy's of violating packaging rules

The US government's Consumer Product Safety Commission (CPSC) had accused Dr. Reddy's of violating packaging rules for some prescription drugs between 2008 and 2012. Dr. Reddy's, in its stock exchange filing had said that packaging was intended to prevent children from ingesting harmful substances. CPSC was planning to file a case against Dr. Reddy's laboratories to seek civil penalties for violating the rules.

6 Nov 2015
Dr. Reddy's gets warning letter from USFDA

Dr. Reddy's labs was issued a warning letter by US Food and Drug Administration (USFDA) raising concerns over quality compliance and manufacturing practices followed at its three plants. The warning was issued following the inspection of its pharmaceutical ingredients manufacturing facilities in Andhra Pradesh and Telangana, as well as oncology formulation manufacturing facility at Visakhapatnam. The company is required to respond in 15 days.

6 Nov 2015
USFDA warning lead to decline in Dr. Reddy's shares

USFDA had conducted inspections of Dr. Reddy's plants in November 2014, January 2015 and February 2015 and issued a warning on November 6. Following the warning, the company's share price on BSE declined by Rs.565.60 (13.3%) to Rs.3687 from the previous close of Rs.4252.60. The company's CEO Prasad said that they would actively engage with the agency to resolve the issues.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Kartikeya Jain
Kartikeya Jain
Mail
Latest
Latest
IPL 2022: CSK's Ravindra Jadeja ruled out of remaining matches
IPL 2022: CSK's Ravindra Jadeja ruled out of remaining matches Sports
ED arrests IAS officer Pooja Singhal in money laundering case
ED arrests IAS officer Pooja Singhal in money laundering case India
Here's why Jacqueline Fernandez has approached court to travel abroad
Here's why Jacqueline Fernandez has approached court to travel abroad Entertainment
Tomato flu afflicts 80 Kerala kids: Know symptoms, prevention tips
Tomato flu afflicts 80 Kerala kids: Know symptoms, prevention tips India
Nayanthara, Vignesh Shivan's rumored wedding: Everything we know so far
Nayanthara, Vignesh Shivan's rumored wedding: Everything we know so far Entertainment
Next News Article
Next News Article

Love Business news?

Subscribe to stay updated.

Business Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022